Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?

To: Fangorn who wrote (1375)	3/1/2000 1:04:00 PM
From: nohalo	Read Replies (1) \| Respond to of 2344

Please sell some more<ggg>

To: Fangorn who wrote (1375)	3/1/2000 1:04:00 PM
From: John Curtis	Read Replies (1) \| Respond to of 2344

Bluevoodoo, Debra, Jibacao, et.al.: Bio-tech appears to have regained favor, so without a doubt such as BIOM are doing well right now. As has been said by others, including the talking heads of such as CNBC, after years of development the bio-tech sector "seeds" look ready to break through the soil with some end products of high efficacy. And Bluevoo's article probably put some nice focus on BIOM, too. All-n-all I still see no reason to abandon this speculation. The bias is nicely positive(after a weee bit of backing & filling), such news as has been gleaned indicates their "Lexus" product, Theratope, is on track, and if I didn't know better I'd say BIOM's under steady accumulation. It looks like things could look reeally great by years end. Meanwhile, I'm enjoying the ride. Jib: I concur with others, thanks for all the excellent postings! Deb; I'm waaay beyond goosebumps. Do goose mountains apply? Heh! And Colin; ain't that always the way? You exercise patience, patience, patience, end up saying "screw it", and the very next day guess who becomes the screwee? ;-) Been there, done that, and it'll probably happen again. Still, to mitigate the possibility 'tis always a good idea to maintain a diversified portfolio. You become less obsessive over one equity that way. Now let's see how BIOM closes(speaking of obsessive). John~